FDA New Drug and Biologic Approvals, 2018 Midyear Review

Mary L Windle, PharmD


August 01, 2018

In This Article

New Indications

Pediatric Multiple Sclerosis: Gilenya (fingolimod)

First drug approved for children with multiple sclerosis.

Pediatric Partial Onset Seizures: Briviact (brivaracetam)

Indication for partial onset seizures expanded to include children aged 4 years or older.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.